a nonsignificant trendP = .15
Lumateperone, however, showed a nonsignificant trend toward better efficacy (MD = −2.79; 95% CI, −6.60 to 1.01; P = .15) ( Figure 3 ).
Lumateperone, however, showed a nonsignificant trend toward better efficacy (MD = −2.79; 95% CI, −6.60 to 1.01; P = .15) ( Figure 3 ).
Lumateperone, however, did not reach statistical significance (MD = −2.79; 95% CI, −6.60 to 1.01).